Study on outcomes of patients undergoing stem cell transplantation

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study collects clinical data from patients who have undergone or are proposed to undergo allogeneic hematopoietic stem cell transplantation. It aims to evaluate the natural course of the disease and current treatment modalities by analyzing treatment regimens, duration, and healthcare expenditures. Patients will complete questionnaires regarding their demographics and disease history, while treatment decisions will be made by their physicians based on standard practices. The study will follow patients over time, even if they participate in other interventional trials.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. At least one visit to a stem cell transplant center beginning January 1, 2021
2. Proposed to undergo or have undergone hematopoietic stem cell transplantation

Exclusion Criteria:

1. Long-term follow-up information for patients not available for any reason (e.g., unavailable or with serious concomitant disease) according to investigator opinion
2. Due to alcohol and drug addiction thus affecting their ability to follow the requirements of the study
3. Presence of conditions that could jeopardize patient safety or affect their adherence to the protocol, according to the investigator's opinion

Where it's running

• Ruijin Hospital, Shanghai Jiaotong University School of Medicine
  Shanghai, Shanghai Municipality, China Recruiting
• Shanghai Liquan Hospital
  Shanghai, China Not yet recruiting
• Shanghai Zhaxin Hospital
  Shanghai, China Not yet recruiting

Study contacts

• Study coordinator: Xiaoxia Hu
• Email: hu_xiaoxia@126.com
• Phone: (86) 13795437259

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Long-term心理 and cognitive check after stem cell transplant for immune deficiencies

  This study tests the long-term neurocognitive and psychological functioning of 6–8 year-old children who had an allogeneic stem cell transplant for a primary immune deficiency, at least two years after the transplant.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris · NCT07766304

• Low-dose Liposomal Amphotericin B for preventing fungal infections in adults with blood cancers and prolonged neutropenia

  This study tests whether giving a daily 50 mg dose of liposomal amphotericin B can help prevent invasive fungal infections in adults with blood cancers who have prolonged low white blood cell counts.

  Recruiting Haikou Affiliated Hospital of Central South University Xiangya School of Medicine · Hainan, Hainan · NCT07763054

• Moxibustion with second-line treatment for steroid-refractory acute graft-versus-host disease after transplant

  This study will test whether adding moxibustion to standard second-line drug therapy helps people aged 14–65 with steroid-refractory gastrointestinal acute GVHD after an allogeneic stem cell transplant.

  Recruiting Phase 2 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan, Hubei · NCT07572669

• Baricitinib for persistent low platelets after stem cell transplant

  We’re testing baricitinib to see if it can help people with long-term low platelets after an allogeneic stem cell transplant who didn’t respond to other treatments.

  Recruiting Phase 1/2 Peking University People's Hospital · Beijing, Beijing Municipality · NCT07535645

• Adding venetoclax to fludarabine–melphalan conditioning for people over 50 with AML or MDS getting a donor stem cell transplant

  This tests whether adding venetoclax to standard fludarabine–melphalan conditioning helps people over 50 with AML or MDS who are having an allogeneic stem cell transplant.

  Recruiting at 18 sites Phase 3 First Affiliated Hospital of Zhejiang University · Fuzhou, Fujian and 17 other locations · NCT07396480

• Cardiovascular problems after allogeneic stem cell transplant

  This study looks at heart-related problems after allogeneic hematopoietic stem cell transplantation to see how often they occur and what factors might predict them.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris · NCT07157670

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.